This Sunday, November 15: 60 Minutes begins its two-part series on CBS, starting with novel synthetic drugs. The kratom report follows November 22.
Set a reminder for both.
Timothy Ketchum’s addiction began with the kratom drink Feel Free. The Wall Street Journal shares his struggle and path toward recovery. “Natural” does not mean risk-free.
on.wsj.com/4zEw2pM
Coming to 60 Minutes:
November 15: Novel synthetic drugs
November 22: Kratom
Two broadcasts worth watching. Mark your calendars and tune in on CBS.
Ordinary kratom leaves can also cause dependence and withdrawal. Matt Rossheim explains why the safety conversation needs to include the leaf itself.
thewellnews.com/opinions/the…
Dr. Marianne Chai describes a student who used kratom tea for anxiety and later experienced opioid withdrawal. We are working to end kratom addiction through awareness and accountability.
childmind.org/article/kratom…
2
2
101
Students deserve to know kratom’s addiction risks before trying it for stress or studying. We are working to end kratom addiction and put student health ahead of wellness promises.
childmind.org/article/kratom…
46
Kratom safety claims deserve scrutiny. Consumers deserve clear evidence and full disclosure of financial ties behind industry advocacy. We are working to end kratom addiction and put public health ahead of financial interests.
2
3
112
A product’s availability is not proof of safety. The global kratom trade deserves scrutiny. We are working to end kratom addiction, challenge misleading wellness claims, and protect families. Public health must come first.
The FDA reports newborn withdrawal after kratom exposure during pregnancy. Families deserve to know this risk. We are fighting to end kratom addiction, challenge misleading wellness claims, and protect families.
Hilary Tesluck shares her experience with kratom addiction in The New York Times. We’re grateful she’s speaking out. Consumers deserve honest information, and people struggling deserve support without shame.
nytimes.com/2026/11/02/well/…
1
3
98
Consumers should not be test subjects. The AMA warns about serious harms from inadequately evaluated botanical products, including kratom. We support rigorous research, honest information, and accountability.
Six national law enforcement and prosecutor organizations are urging emergency Schedule I control of all kratom. Their October 30 letter calls on DEA and FDA to act. We stand with families seeking stronger protections.
Natural is not a substitute for evidence. The AMA is calling for FDA oversight and clinical trials before kratom and other botanicals are marketed as treatments. We support clear standards that put patient safety first.
Benjamin McCann took kratom for arthritis pain, believing it was safe and natural, his mother says. Kelli McCann attributes his death to mitragynine intoxication and is urging Montana communities to act. Families deserve to be heard.
1
59
The public physician registry is empty under its stated criteria. That does not prove no doctor has ever recommended kratom. It does leave a fair challenge: show the documented medical recommendations behind the health claims.
36
The industry says “natural leaf.” But the body can convert kratom’s mitragynine into 7-OH, an opioid. We believe consumers deserve that information before buying a product marketed for wellness. “Natural” does not settle the safety question.
#kratomawareness
7
3
234
Where are the physicians publicly recommending kratom as a medical treatment? We’re asking for names, credentials, and clinical evidence. Industry testimonials are not medical endorsement. Families deserve more than a sales pitch.
#kratomawareness
4
80
The kratom industry is celebrating the recent scheduling thresholds as a victory. DEA has not found below-threshold levels safe. FDA continues to warn about liver toxicity, seizures and substance use disorder.
Learn more: endkratomaddiction.org
#kratomawareness
Luke Niforatos challenged the AKA: OPMS faces over 20 wrongful death lawsuits. The scrutiny of OPMS and its cofounders, David Gabbay and Peyton Palaio, must continue.
Thank you, Luke, for pressing for accountability.
Learn more: endkratomaddiction.org
#kratomawareness
“Kratom meets both the pharmacological and functional definitions of an opioid.”
From the Journal of Clinical Psychopharmacology’s new guest editorial. Policymakers need to pay attention.
doi.org/10.1097/JCP.00000000…
#kratomawareness
32
















